Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
  1. 4 Open-market buy Director bought 38,710 shares at $5.26 ($203,615)
  2. 4 Open-market buy Director bought 2,839 shares at an average $4.99 ($14,171)
  3. 4 Open-market buy Director bought 4,404,162 shares at an average $3.29 ($14,500,672)
  4. 4 Open-market buy 10% owner bought 20,829 shares at $3.25 ($67,694)
  5. 4 Open-market buy Director bought 42,726 shares at $3.25 ($138,860)
  6. 4 Open-market buy Director bought 6,943 shares at $3.25 ($22,565)
  7. 4 Open-market buy Director bought 833,153 shares at $3.25 ($2,707,747)
  8. 4 Open-market buy Director bought 833,153 shares at $3.25 ($2,707,747)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Director acquired 18,564 shares (grant or award)
  14. 4 Grant or award Director acquired 18,564 shares (grant or award)
  15. 4 Grant or award Director acquired 18,564 shares (grant or award)
  16. 4 Grant or award VP and General Counsel acquired 26,918 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 34,035 shares (grant or award)
  18. 4 Grant or award Chief Commercial Officer acquired 32,488 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 27,847 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 88,181 shares (grant or award)

Page 12 of 17 · 321 filings